<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>General Pharmacology - Pharmacology and Pharmacotherapeutics</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="../styles/main.css">
    
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <!-- Floating Table of Contents -->
    <div class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span>
            <span>Contents</span>
        </div>
        <ul class="floating-toc-list">
            <!-- JS will populate this -->
        </ul>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>üíä</span>
                        <span>Section I</span>
                    </div>
                    <h1 class="document-title">General Pharmacology</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>General Considerations & Pharmacokinetics</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>45 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- START: Chapter 1 -->
                    <section class="content-section" id="chapter-1">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üî¨</span>
                                General Considerations and Pharmacokinetics
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Illness has been man's heritage from the beginning of his existence, and the search for remedies to combat it is perhaps equally old. The world's oldest known therapeutic writings come from India and China. The earliest Indian records are the Vedas. Although there are medical descriptions in Rigveda (3000 B.C.), Ayurveda, the science of life advocates various medicinal preparations of herbal and mineral origin. These are presented in ancient treatise Charaka samhita, Sushruta samhita and Vagbhata.</p>
                            
                            <p>Modern medicine is considered to date from Hippocrates, a Greek physician (450 B.C.), who for the first time introduced the concept of disease as a pathologic process and tried to organise the science of medicine on the basis of observation, analysis and deduction.</p>

                            <p>The word <dfn class="term-definition" data-definition="The science that deals with drugs. Derived from Pharmacon (an active principle) and logos (a discourse).">Pharmacology</dfn> is derived from two Greek words Pharmacon (an active principle) and logos (a discourse or treatise). It is the science that deals with drugs. Development of modern pharmacology as a science is fairly recent and probably started taking shape following the introduction of experimental procedures in animals by Francois Magendie (1783-1855) and Claude Bernard (1813-1878).</p>

                            <p>Pharmacology consists of detailed study of drugs, particularly their actions on living animals, organs and tissues. The actions may be beneficial or harmful. The object of pharmacology is mainly to provide such scientific data, using which one can choose a drug treatment of proven efficacy and safety from the various options available, to suit the patient.</p>

                            <div class="callout callout--info">
                                <div class="callout-header">
                                    <span class="callout-icon">üìö</span>
                                    <h4 class="callout-title">Branches of Pharmacology</h4>
                                </div>
                                <div class="callout-content">
                                    <ul>
                                        <li><strong>Pharmacognosy</strong> is the science of identification of drugs from natural sources.</li>
                                        <li><strong>Pharmacy</strong> is the science of identification, selection, preservation, standardisation, compounding and dispensing of medicinal substances.</li>
                                        <li><strong>Clinical pharmacy</strong> is the science of drug formulations, their stability, shelf life, handling and also education of the patient about compliance and counselling him on how to take the medication, and monitoring for errors in drug therapy.</li>
                                        <li><strong>Pharmacokinetics</strong> is a study of absorption, distribution, metabolism and excretion of drugs, and their relationship to pharmacologic response (what the body does to a drug).</li>
                                        <li><strong>Pharmacodynamics</strong> is the quantitative study of the effects of drugs (what the drug does to the body). Such studies elucidate the site and mechanism of drug action (Fig. 1.1).</li>
                                        <li><strong>Therapeutics</strong> is a branch of medicine concerned with prevention and cure of disease or relief of symptoms.</li>
                                        <li><strong>Toxicology</strong> is the science of poisons which includes detection and knowledge about the nature and effects of poisons as well as treatment of poisoning.</li>
                                        <li><strong>Chemotherapy</strong> is concerned with the effect of drugs upon microorganisms and parasites, living and multiplying in a living organism. It now includes the drug treatment of cancer as well.</li>
                                        <li><strong>Pharmacoepidemiology</strong> is the study of the use and effects of drugs in large number of people.</li>
                                        <li><strong>Pharmacoeconomics</strong> is the analysis of the cost of drug therapy and its benefits to the health care system and the society.</li>
                                        <li><strong>Pharmacovigilance</strong> is the process of identifying and responding to the issues of drug safety through the detection of drug effects, usually adverse.</li>
                                        <li><strong>Pharmacogenetics</strong> is the study of genetic basis for variations in drug metabolism and response in humans.</li>
                                        <li><strong>Pharmacogenomics</strong> is the science that examines genomic variability to assess its effects on the drug response of humans, microbes and tumours.</li>
                                        <li><strong>Pharmacometrics</strong> is a science that deals with evolving a quantitative relationship between exposure to the drug (pharmacokinetics) and its response (pharmacodynamics).</li>
                                    </ul>
                                </div>
                            </div>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251214-194f3ebe.jpeg" 
                                         alt="Relationship between Pharmacokinetics and Pharmacodynamics" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 1.1: Relationship between Pharmacokinetics and Pharmacodynamics</figcaption>
                            </figure>

                            <p>The word <dfn class="term-definition" data-definition="Any substance used for the purpose of diagnosis, prevention, relief or cure of a disease in man or animals.">drug</dfn> is derived from the French word 'drogue', a dry herb. A drug is defined as any substance used for the purpose of diagnosis, prevention, relief or cure of a disease in man or animals. According to WHO, "A drug is any substance or product that is used or intended to be used to modify or explore physiological systems or pathological states for the benefit of the recipient."</p>

                            <h3>The Nature and Sources of Drugs</h3>
                            <p>The various sources of drugs are:</p>
                            <ul>
                                <li><strong>I Mineral:</strong> e.g. Liquid paraffin, Magnesium sulfate, Kaolin and Aluminium trisilicate.</li>
                                <li><strong>II Animal:</strong> e.g. Insulin, Heparin, Gonadotropins, and Antitoxic sera.</li>
                                <li><strong>III Plant:</strong> e.g. Morphine, Digoxin, Quinine, Atropine and Reserpine. Plants contain mixtures of several chemical constituents (Table 1.1), which vary from plant to plant.</li>
                                <li><strong>IV Micro-organisms:</strong> Bacteria and Fungi, isolated from soil, are important sources of antibacterial substances, e.g., Penicillin.</li>
                                <li><strong>V Synthetic:</strong> e.g. Non-steroidal antiinflammatory drugs, Hypnotics, Anticancer drugs and ACE inhibitors. Majority of the drugs currently used in therapeutics are synthetic.</li>
                                <li><strong>VI Genetic engineering (DNA recombinant technology):</strong> e.g. Insulin and Hepatitis B Vaccine.</li>
                                <li><strong>VII Biologicals:</strong> In the last decade many biological agents have also become available for therapeutic purposes. This is a heterogeneous group and includes complex protein molecules that interact with cytokines or cell surface markers e.g. growth factors, monoclonal antibodies, cytokines.</li>
                            </ul>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 1.1: Plant constituents</caption>
                                    <thead>
                                        <tr>
                                            <th>Active principle</th>
                                            <th>Nature and source</th>
                                            <th>Examples and uses</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Alkaloids</strong></td>
                                            <td>Water-soluble salts or water-insoluble nitrogenous compounds.</td>
                                            <td>Morphine, Atropine, Emetine, Vincristine.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Glycosides</strong></td>
                                            <td>Ether linkages of sugar with other organic structures. Acid hydrolysis separates sugar from non-sugar moiety (aglycone or genin).</td>
                                            <td>Digoxin</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Fixed oils</strong></td>
                                            <td>Non-volatile edible/non-edible glycerides of oleic, palmitic and stearic acids.</td>
                                            <td>Olive, peanut and coconut oils, and castor oil.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Volatile oils</strong> (Essential or flavouring oils)</td>
                                            <td>Terpenes or their polymers. Volatile and possess aroma. No caloric value.</td>
                                            <td>Peppermint oil: diluent, solvent and flavouring agent. Ginger, Asafoetida and Eucalyptus oil: carminative. Thymol: antiseptic. Oil of Wintergreen, and Turpentine: counterirritant. Oil of Clove: toothache relief.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Mineral oils</strong></td>
                                            <td>Hydrocarbons derived from petroleum. No food value.</td>
                                            <td>Liquid paraffin: lubricant laxative.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Resins</strong></td>
                                            <td>Oxidised or polymerised volatile oils.</td>
                                            <td>Tincture benzoin: antiseptic.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Oleoresins</strong></td>
                                            <td>Mixture of volatile oils and resins.</td>
                                            <td></td>
                                        </tr>
                                        <tr>
                                            <td><strong>Gums</strong></td>
                                            <td>Secretory products of plants. They form thick, mucilaginous colloids with water.</td>
                                            <td>Gum acacia and gum tragacanth: suspending and emulsifying agents.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Tannins</strong></td>
                                            <td>Non-nitrogenous phenolic water soluble constituents.</td>
                                            <td>Tincture catechu: astringent (precipitates proteins) and protective to mucous membranes</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Miscellaneous</strong></td>
                                            <td>Antibacterial substances, Flavonoids, Retinoids, Phytoestrogens, Sterols.</td>
                                            <td>Varied</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <p>Apart from drugs, gene based therapy and stem cell therapy are available today.</p>
                            <p><strong>Gene based therapy:</strong> The developments in biotechnology, including recombinant DNA technology, have made it possible to synthesise short nucleotide sequences (genes). These are responsible for the in-vivo synthesis of proteins critical in certain metabolic pathways. They can be introduced into human beings for therapeutic purposes. The object of gene therapy is to introduce functional genetic material into mammalian cells to replace or supplement the activity of defective genes.</p>
                            <p><strong>Stem cell therapy:</strong> Recently stem cells (either embryonic or adult pleuripotent cells) have been used as a therapeutic approach for regeneration and proliferation of functional cells in the body e.g. in myocardial infarction, osteoarthritis and diabetes mellitus.</p>
                            <p><strong>Nanomedicines:</strong> These are synthesised using nanotechnology. The latter is defined as the intentional design, characterisation, production and applications of materials, structures, devices and systems by controlling their size and shape in the nanoscale range (1 to 100 nm). Nanomedicines are close to biological molecules in size and have very high surface/volume ratio.</p>

                            <h3>Routes of Drug Administration and Dosage Forms</h3>
                            <p>Drugs may be applied locally, or may be administered orally and or by injection.</p>

                            <details class="collapsible-section">
                                <summary class="collapsible-trigger">
                                    <span class="trigger-icon">‚ñ∂</span>
                                    <span class="trigger-text">Local application</span>
                                </summary>
                                <div class="collapsible-content">
                                    <p>Dusting powder, paste, lotion, drops, ointment or plaster exert action at the site of application (topical action). Drugs may also be administered locally in the following forms: bougie for urethra, pessary for vagina, inhalers for bronchi, and suppository for the vagina and rectum.</p>
                                    <p>Drugs used as aqueous solutions for local effects on mucous membranes are likely to be absorbed and may produce adverse systemic effects. In case of corneal application, the drug may penetrate into the anterior chamber and affect the ciliary muscle e.g. cocaine.</p>
                                    <p>Administration of a medicament in a liquid form into the rectum is called enema. Enemata are of two types:</p>
                                    <ul>
                                        <li><strong>Evacuant enema:</strong> e.g. soap water enema. The aim is to remove the faecal matter and the flatus. The quantity of fluid administered is about 600 ml.</li>
                                        <li><strong>Retention enema:</strong> The fluid containing the drug is retained in the rectum for local action as with prednisolone enema for ulcerative colitis; or it may act systemically after absorption through the mucous membrane. The quantity of fluid administered is usually 100-120 ml.</li>
                                    </ul>
                                </div>
                            </details>

                            <details class="collapsible-section">
                                <summary class="collapsible-trigger">
                                    <span class="trigger-icon">‚ñ∂</span>
                                    <span class="trigger-text">Oral or Enteral route</span>
                                </summary>
                                <div class="collapsible-content">
                                    <p>This is the most commonly employed route for drug administration. Its advantages are:</p>
                                    <ul>
                                        <li>Convenient and safe</li>
                                        <li>Economical</li>
                                        <li>Complications of parenteral therapy are avoided.</li>
                                    </ul>
                                    <p>However, it has the following disadvantages:</p>
                                    <ul>
                                        <li>The onset of drug action is tardy.</li>
                                        <li>Irritant and unpalatable drugs cannot be administered by this route.</li>
                                        <li>The absorption of certain drugs can be irregular or negligible e.g. aminoglycosides.</li>
                                        <li>The route may not be useful in the presence of vomiting and diarrhoea.</li>
                                        <li>The route cannot be employed in an unconscious or uncooperative patient nor in an emergency; and</li>
                                        <li>Drugs likely to be destroyed by digestive juices cannot be administered orally e.g. insulin and enzymes for systemic action. Further, certain drugs like testosterone though absorbed, get inactivated in the intestinal wall and the liver (first pass metabolism) and only a small portion reaches the systemic circulation.</li>
                                    </ul>
                                    <p><strong>Enteric coated tablets:</strong> Sometimes, tablets are coated with cellulose-acetate-phthalate, gluten and anionic co-polymers of methacrylic acid and its esters. These substances resist the acid juice of the stomach but permit disintegration in the intestinal alkaline juices. Enteric coating is done to:</p>
                                    <ul>
                                        <li>Prevent gastric irritation and destruction of the drug in the stomach.</li>
                                        <li>Achieve the desired concentration of the drug in the small intestine; and</li>
                                        <li>Retard the absorption of the drug.</li>
                                    </ul>
                                    <figure class="content-figure" data-lightbox="true">
                                        <div class="figure-image-wrapper">
                                            <img src="../../../../../assets/images/image-20251214-e1ae5943.jpeg" 
                                                 alt="Radiographs showing intact tablets in the GI tract" 
                                                 class="figure-image"
                                                 loading="lazy">
                                            <div class="figure-overlay">
                                                <span class="overlay-icon">üîç</span>
                                                <span class="overlay-text">Click to enlarge</span>
                                            </div>
                                        </div>
                                        <figcaption class="figure-caption">Fig. 1.2: Radiographs (A&B) showing intact tablets in the GI tract. Arrows indicate presence of tablets which are not dissolved.</figcaption>
                                    </figure>
                                    <p><strong>Controlled release (CR) and time release preparations</strong> (Timsules, Spansules) release the drug over an extended period of time. Such preparations have the particles of drug covered with coatings which dissolve at different time intervals.</p>
                                </div>
                            </details>

                            <details class="collapsible-section">
                                <summary class="collapsible-trigger">
                                    <span class="trigger-icon">‚ñ∂</span>
                                    <span class="trigger-text">Parenteral routes</span>
                                </summary>
                                <div class="collapsible-content">
                                    <p>Routes of administration other than the alimentary tract (the enteron) are called parenteral. Its advantages are:</p>
                                    <ul>
                                        <li>They can be employed in an unconscious or an uncooperative patient.</li>
                                        <li>They can be employed in cases of vomiting and diarrhoea and in patients unable to swallow.</li>
                                        <li>Drugs which might irritate the stomach or which are not absorbed orally can be administered.</li>
                                        <li>They avoid drug modification by the alimentary juices and liver enzymes; and</li>
                                        <li>Rapid action and accuracy of dose are ensured.</li>
                                    </ul>
                                    <p>The parenteral routes are:</p>
                                    <ul>
                                        <li><strong>I Inhalation:</strong> Drugs may be administered by this route using pressurised aerosols, dry powders, or nebulised solutions. Drugs go directly to the left side of the heart through the pulmonary veins.</li>
                                        <li><strong>II Injections:</strong>
                                            <ul>
                                                <li><strong>Intradermal (ID):</strong> This is given into the layers of the skin e.g. BCG vaccine.</li>
                                                <li><strong>Subcutaneous (SC):</strong> Only non-irritant substances can be injected by this route. The commonest drug used by this route is insulin.</li>
                                                <li><strong>Intramuscular (IM):</strong> In addition to soluble substances, mild irritants, suspensions and colloids can be injected by this route. The rate of absorption is reasonably uniform and the onset of action is rapid.</li>
                                                <li><strong>Intravenous (IV):</strong> Drugs given directly into a vein produce very rapid action, and the desired blood concentration can be obtained rapidly with a smaller dose. Titration of the dose is possible.</li>
                                            </ul>
                                        </li>
                                    </ul>
                                    <div class="callout callout--warning">
                                        <div class="callout-header">
                                            <span class="callout-icon">‚ö†Ô∏è</span>
                                            <h4 class="callout-title">Irritants on IV administration</h4>
                                        </div>
                                        <div class="callout-content">
                                            <p>Acidic, alkaline or hypertonic solutions, Potassium and calcium solutions, Parenteral nutrient solutions, Aminophylline, Iron, Cancer chemotherapy agents, Quinine, thiopental, phenytoin, diazepam, tetracycline, nitroglycerine, ethyl alcohol, radiocontrast media, propylene glycol, vasopressors.</p>
                                        </div>
                                    </div>
                                    <p><strong>Intra-arterial</strong> drug administration produces a sudden high concentration in arterial blood.</p>
                                    <p><strong>Intrathecal</strong> administration involves introduction of drugs such as spinal anaesthetics into the subarachnoid space.</p>
                                    <p><strong>Intraperitoneal</strong> route has been sometimes used in infants for giving fluids like glucose saline.</p>
                                    <p><strong>Intraosseous (intramedullary) cannulation:</strong> Drugs injected into the bone marrow of the iliac crest or the tibia are rapidly absorbed into the circulation.</p>
                                </div>
                            </details>

                            <details class="collapsible-section">
                                <summary class="collapsible-trigger">
                                    <span class="trigger-icon">‚ñ∂</span>
                                    <span class="trigger-text">Transcutaneous/Transdermal</span>
                                </summary>
                                <div class="collapsible-content">
                                    <p><strong>Iontophoresis:</strong> In this procedure, a galvanic current allows the penetration of drugs applied to the skin into the deeper tissues.</p>
                                    <p><strong>Inunction:</strong> Certain drugs when rubbed into the skin (inunction) can get absorbed and produce systemic effects e.g. nitroglycerin ointment.</p>
                                    <p><strong>Jet injection (Dermojet):</strong> This needleless method involves the transcutaneous introduction of a drug by means of a high velocity jet produced through a micro-fine orifice.</p>
                                    <p><strong>Transdermal delivery system:</strong> It is available as an adhesive unit to deliver drugs slowly through skin producing prolonged systemic effect e.g. scopolamine for prevention of motion sickness.</p>
                                </div>
                            </details>

                            <details class="collapsible-section">
                                <summary class="collapsible-trigger">
                                    <span class="trigger-icon">‚ñ∂</span>
                                    <span class="trigger-text">Trans-mucosal</span>
                                </summary>
                                <div class="collapsible-content">
                                    <p><strong>Sublingual administration:</strong> A tablet containing a medicament is placed under the tongue and is allowed to dissolve in the mouth. The active agent thus gets absorbed through the buccal mucous membrane directly into the systemic circulation. Advantages of this route are:</p>
                                    <ul>
                                        <li>Can be employed in patients who are vomiting.</li>
                                        <li>Rapid onset of action.</li>
                                        <li>Quick termination of the drug effect on spitting the tablet.</li>
                                        <li>Avoidance of degradation of the drug in the stomach; and</li>
                                        <li>Bypassing its rapid inactivation in the intestinal wall and the liver (first pass).</li>
                                    </ul>
                                    <p><strong>Trans-nasal route:</strong> DAVP, a synthetic analogue of vasopressin, GnRH agonist (nafarelin) and calcitonin are the drugs administered by this route.</p>
                                    <p><strong>Trans-rectal route:</strong> The rectum has rich blood and lymph supply, and drugs can cross the rectal mucosa like the other lipid membranes. Approximately 50% of drug absorbed by the rectum bypasses the liver.</p>
                                </div>
                            </details>

                            <h3>Absorption and Bioavailability</h3>
                            <p>Absorption is the process by which drugs enter the systemic circulation. Molecules, including drug molecules, cross a biological membrane by:</p>
                            <ul>
                                <li><strong>Simple or passive diffusion:</strong> Drug molecules move across the cell membrane, in proportion to their concentration, from higher to lower concentration. This includes lipid diffusion and aqueous diffusion.</li>
                                <li><strong>Transport using transmembrane transporters:</strong> Transporters are proteins located across the mucosal cells. They may be Solute carriers (SLC) or ATP binding cassettes (ABC) family.</li>
                                <li><strong>Facilitated diffusion:</strong> An SLC spanning the cell membrane moves molecules down the chemical/concentration gradient.</li>
                                <li><strong>Active transport:</strong> Requires input of energy to move molecules uphill against the chemical or electrical gradient.</li>
                                <li><strong>Endocytosis:</strong> Includes receptor mediated endocytosis and pinocytosis.</li>
                            </ul>

                            <p><dfn class="term-definition" data-definition="The amount or percentage of an active drug that is absorbed from a given dosage form following its non-vascular administration, and reaches systemic circulation.">Bioavailability</dfn> (F) is determined by comparing the AUC after oral administration of a drug with the AUC after IV administration of the same dose of the drug.</p>
                            <div class="equation">
                                $$ \mathrm{F}=\frac{\text { AUC after oral dose }}{\text { AUC after IV dose }} \times 100 $$
                            </div>
                            
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251214-197d65eb.jpeg" 
                                         alt="Plasma drug level curves" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 1.3: The plasma drug level curves following oral administration of three formulations of the same basic drug.</figcaption>
                            </figure>

                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üí°</span>
                                    <h4 class="callout-title">Factors Affecting Drug Absorption</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Factors affecting oral drug absorption and its bioavailability include:</p>
                                    <ul>
                                        <li><strong>Physical properties:</strong> Lipid or water solubility, physical state.</li>
                                        <li><strong>Dosage forms:</strong> Particle size, disintegration time, dissolution rate, formulation.</li>
                                        <li><strong>Physiological factors:</strong> Ionisation, pH of GI fluid, GI transit time, enterohepatic cycling, absorbing surface area, first pass elimination.</li>
                                        <li><strong>Presence of other agents:</strong> Food (Table 1.5) or other drugs.</li>
                                        <li><strong>Pharmacogenetic factors</strong></li>
                                        <li><strong>Disease states</strong></li>
                                    </ul>
                                </div>
                            </div>

                            <h3>Distribution of a Drug</h3>
                            <p>After absorption, a drug enters or passes through the several body fluid compartments. The <dfn class="term-definition" data-definition="The volume into which the total amount of a drug in the body appears to be uniformly distributed.">apparent volume of distribution</dfn> ($V_d$) is calculated as:</p>
                            <div class="equation">
                                $$ V_{d}(L)=\frac{\text { Total amount administered }}{\text { Plasma concentration }} $$
                            </div>

                            <p><strong>Plasma concentration of a drug</strong> depends upon the drug's rate of absorption, distribution, metabolism, and excretion.</p>

                            <p><strong>Protein Binding:</strong> After absorption, the drug circulates in the blood either in the free form or bound to plasma proteins. Protein binding affects bioavailability, duration of action, and elimination.</p>

                            <p><strong>Blood-Brain Barrier (BBB):</strong> The endothelial cells of the brain capillaries do not permit bulk passage of water and solutes (tight junctions). Only lipid soluble drugs or those with specific transporters can cross. P-glycoproteins act as efflux pumps to extrude drugs from the brain.</p>

                            <h3>Fate of a Drug (Metabolism)</h3>
                            <p>The changes that a drug undergoes in the body and its ultimate elimination are considered as the fate of the drug. Biotransformation usually inactivates an active drug, activates an inactive drug (prodrug), or generates active metabolites.</p>
                            <p><strong>Phase I reactions (Non-synthetic):</strong> Oxidation, Reduction, Hydrolysis. These introduce polar groups into drugs making them water soluble. Important enzymes include the Cytochrome P450 (CYP) superfamily.</p>
                            <p><strong>Phase II reactions (Synthetic):</strong> Conjugation or transfer reaction. This involves combining the drug/metabolite with an endogenous substance (glucuronic acid, sulfuric acid, etc.) to form water-soluble conjugates for excretion.</p>

                            <h3>Drug Excretion</h3>
                            <p>Drugs and metabolites are excreted via:</p>
                            <ul>
                                <li><strong>Kidneys:</strong> Through passive glomerular filtration, active tubular secretion (e.g. by P-glycoprotein, MRP2), and passive tubular reabsorption.</li>
                                <li><strong>Lungs:</strong> Volatile anaesthetics, alcohol.</li>
                                <li><strong>Bile:</strong> Active secretion into bile; may lead to enterohepatic circulation.</li>
                                <li><strong>Intestines</strong></li>
                                <li><strong>Skin, Saliva, and Milk</strong></li>
                            </ul>

                            <h3>Plasma Half-life and Kinetics</h3>
                            <p>Elimination of most drugs follows <strong>First Order Kinetics</strong> (exponential), where a constant fraction of the drug is eliminated per unit time. The half-life ($t^{1/2}$) is constant.</p>
                            <div class="equation">
                                $$ \mathrm{t}^{1 / 2}=\frac{0.693}{\mathrm{~K}} $$
                            </div>
                            <p>Some drugs follow <strong>Zero Order Kinetics</strong> (saturation kinetics), where a fixed quantity of drug is eliminated per unit time (e.g., phenytoin, alcohol). This leads to disproportionate increase in plasma levels with dose increases.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251214-9940297d.jpeg" 
                                         alt="Comparison of non-saturation and saturation kinetics" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 1.5: Comparison of non-saturation (first order) and saturation (zero order) kinetics.</figcaption>
                            </figure>
                        </div>
                    </section>
                    <!-- END: Chapter 1 -->

                    <!-- START: Chapter 2 -->
                    <section class="content-section" id="chapter-2">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚öóÔ∏è</span>
                                Pharmacodynamics
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Site of Drug Action</h3>
                            <p>A drug may act locally (at the point of application) or systemically (after absorption). Methods for localisation include anatomical/physiological ablation, biochemical localisation (enzymes), pharmacological localisation (using blockers), and tracer techniques.</p>

                            <h3>Structure Activity Relationship (SAR)</h3>
                            <p>The activity of a drug is intimately related to its chemical structure. SAR knowledge allows synthesis of new compounds with specific actions, synthesis of competitive antagonists, and understanding mechanisms of action. <strong>Chirality</strong> is important; enantiomers may have different pharmacological actions (e.g., l-atenolol vs d-atenolol).</p>

                            <h3>Mechanism of Drug Action</h3>
                            <p>Drug action (initial interaction) leads to drug effects (physiological consequences). Drugs may act via physical properties (osmosis, adsorption), chemical properties (antacids), or by modulating body function regulators (receptors, enzymes, transport processes, structural proteins).</p>
                            
                            <h3>Drug Receptors</h3>
                            <p>Receptors are specific protein macromolecules. Interaction parameters include <strong>Selectivity</strong> and <strong>Affinity</strong>. <strong>Intrinsic activity (Efficacy)</strong> is the ability to elicit a response.</p>
                            <ul>
                                <li><strong>Agonist:</strong> High affinity, high intrinsic activity.</li>
                                <li><strong>Antagonist:</strong> High affinity, no intrinsic activity (receptor blockade).</li>
                                <li><strong>Partial agonist:</strong> Affinity, but less intrinsic activity than full agonist.</li>
                                <li><strong>Inverse agonist:</strong> Affinity, but produces opposite effect to agonist (negative efficacy).</li>
                            </ul>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 2.1: The main types of receptors</caption>
                                    <thead>
                                        <tr>
                                            <th>Type 1</th>
                                            <th>Type 2</th>
                                            <th>Type 3</th>
                                            <th>Type 4</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Ion channel-linked</strong> (Ionotropic)</td>
                                            <td><strong>G-protein coupled</strong> (Metabotropic)</td>
                                            <td><strong>Protein kinase linked</strong></td>
                                            <td><strong>Nuclear receptors</strong></td>
                                        </tr>
                                        <tr>
                                            <td>Location: Cell membrane</td>
                                            <td>Location: Cell membrane</td>
                                            <td>Location: Cell membrane</td>
                                            <td>Location: Cytosol/Nucleus</td>
                                        </tr>
                                        <tr>
                                            <td>Effector: Channel</td>
                                            <td>Effector: Enzyme or channel</td>
                                            <td>Effector: Enzyme</td>
                                            <td>Effector: Gene</td>
                                        </tr>
                                        <tr>
                                            <td>Response: Milliseconds</td>
                                            <td>Response: Seconds</td>
                                            <td>Response: Hours</td>
                                            <td>Response: Hours</td>
                                        </tr>
                                        <tr>
                                            <td>e.g., nACh, GABA<sub>A</sub></td>
                                            <td>e.g., mACh, Adrenergic</td>
                                            <td>e.g., Insulin</td>
                                            <td>e.g., Steroids</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251214-dec5f426.jpeg" 
                                         alt="Types of receptor-effector linkage" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.2: Types of receptor-effector linkage.</figcaption>
                            </figure>

                            <h3>Dose Response Relationship</h3>
                            <p><strong>Graded dose-response:</strong> Relates size of response in a single biological unit to the dose (Fig 2.3). Indicates efficacy and potency.</p>
                            <p><strong>Quantal dose-response:</strong> Relates frequency of a fixed (all-or-none) response in a population to the dose (Fig 2.5). Used to determine ED<sub>50</sub> and LD<sub>50</sub>.</p>
                            <p><strong>Therapeutic Index (TI):</strong> Ratio of median lethal dose to median effective dose ($LD_{50}/ED_{50}$). Indicates safety margin.</p>

                            <h3>Drug Interactions</h3>
                            <ul>
                                <li><strong>Additive:</strong> Total effect = sum of individual effects ($1+1=2$).</li>
                                <li><strong>Synergism:</strong> Total effect > sum of individual effects ($1+1>2$).</li>
                                <li><strong>Antagonism:</strong> Opposing actions.
                                    <ul>
                                        <li><strong>Chemical:</strong> Reaction between agents (e.g. chelators).</li>
                                        <li><strong>Competitive:</strong> Agonist and antagonist compete for same site. Surmountable. Shifts curve right (Fig 2.6a).</li>
                                        <li><strong>Non-competitive:</strong> Antagonist inactivates receptor. Non-surmountable. Depresses max response (Fig 2.6b).</li>
                                        <li><strong>Physiological:</strong> Drugs act on different receptors to produce opposite effects (e.g. Histamine vs Adrenaline).</li>
                                    </ul>
                                </li>
                            </ul>
<h3>Adverse Drugs Reactions (ADR)</h3>
                            <p>The administration of a drug may result in the development of:</p>
                            <ul>
                                <li>Side effects</li>
                                <li>Untoward effects</li>
                                <li>Toxic effects; or</li>
                                <li>Allergic and idiosyncratic effects.</li>
                            </ul>
                            
                            <p><strong>Side effects:</strong> Side effects are in fact pharmacological effects produced with therapeutic dose of the drug, e.g., dryness of mouth with atropine. These effects are neither harmful nor damaging and recovery is quick on stopping the drug or reducing the dose. Side effects which might be troublesome in a particular situation may be useful under other circumstances.</p>

                            <p><strong>Untoward effects:</strong> Untoward effects also develop with therapeutic dose of a drug, but are undesirable and, if severe, may necessitate the cessation of treatment, e.g. resistant staphylococcal diarrhoea following tetracycline therapy and potassium loss due to diuretic drugs.</p>

                            <p><strong>Toxic effects:</strong> These are seen usually when a drug is administered repeatedly and/or in large doses. Toxic effects always cause tissue damage to induce signs and symptoms (toxidromes). The recovery takes longer time and may be partial or impossible. Drug toxicity is usually the primary attribute of a drug and is dose dependent.</p>

                            <p>According to WHO, <dfn class="term-definition" data-definition="Any response to a drug that is noxious and unintended and that occurs at doses used in man for the prophylaxis, diagnosis or therapy of disease.">adverse drug reaction (ADR)</dfn> is defined as "any response to a drug that is noxious and unintended and that occurs at doses used in man for the prophylaxis, diagnosis or therapy of disease or for modification of physiological function". It excludes adverse reactions due to drug overdose (poisoning), drug abuse and therapeutic errors.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251214-34ad6734.jpeg" 
                                         alt="Classification of Adverse Drug Reactions" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.7: Classification of Adverse Drug Reactions.</figcaption>
                            </figure>

                            <p>ADRs are generally classified into Type A (Augmented); Type B (Bizarre); Type C (Chronic) Type D (Delayed) and Type E (End of dose).</p>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 2.2: Comparison between Type A and Type B ADR</caption>
                                    <thead>
                                        <tr>
                                            <th>Feature</th>
                                            <th>Type A</th>
                                            <th>Type B</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Nature of ADR</strong></td>
                                            <td>Augmented/normal response</td>
                                            <td>Totally abnormal, bizarre response</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Mechanism</strong></td>
                                            <td>Hyper-response</td>
                                            <td>Genetic, immunological/unknown</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Pharmacologically predictable</strong></td>
                                            <td>Largely yes</td>
                                            <td>No</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Dose dependent</strong></td>
                                            <td>Yes</td>
                                            <td>No</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Incidence and morbidity</strong></td>
                                            <td>High</td>
                                            <td>Low</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Mortality</strong></td>
                                            <td>Low</td>
                                            <td>High</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Treatment</strong></td>
                                            <td>Adjust dose</td>
                                            <td>Stop the drug</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <p><strong>Idiosyncrasy</strong> is a Type B ADR wherein the abnormal response to a drug is either due to a genetic or unknown mechanism. Thus, sometimes genetically determined absence or reduced activity of certain enzyme(s) in an individual is responsible for the ADR. In many cases, however, the cause of the idiosyncrasy is unknown.</p>

                            <h3>Drug Allergy</h3>
                            <p>'Hypersensitivity' or 'allergic' reactions can occur, when an individual sensitised to an antigen (e.g. drug), again comes in contact with the same antigen. The resulting tissue-damaging reactions are:</p>
                            
                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>(1) Type I (Immediate Hypersensitivity)</h4>
                                    <p>IgE mediated (a) Allergic reaction and (b) Anaphylaxis. The antigen reacts with reaginic antibodies (IgE), bound to the surface of mast cells and basophils, causing degranulation with massive liberation of histamine and other mediators. Mediators released include histamine, PAF, SRS-A, bradykinin.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>(2) Type II (Cytotoxic)</h4>
                                    <p>IgG and IgM antibodies formed bind to an antigen present on the cell surface and promote their destruction by lysis/phagocytosis by polymorphs and macrophages or by non-adherent lymphoid killer cells.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>(3) Type III (Immune Complex Mediated)</h4>
                                    <p>The union of soluble antigen with IgG antibody in vivo forms immune complexes which may ultimately cause histamine release, activation of kinin system and aggregation of platelets. Examples include serum sickness and Arthus reaction.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>(4) Type IV (Cell Mediated/Delayed)</h4>
                                    <p>T-lymphocytes carrying a specific receptor on their surface are activated by the antigen to release certain active factors. This indicates the secondary cellular response appearing at 48-72 hours after the antigen exposure (e.g., contact dermatitis).</p>
                                </div>
                            </div>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251214-88eda4d4.jpeg" 
                                         alt="Atopic allergy and targets for therapy" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.8: Atopic allergy and targets for therapy.</figcaption>
                            </figure>

                            <h3>Treatment of Acute Drug Poisoning</h3>
                            
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 2.4: Principles of treatment of acute poisoning</caption>
                                    <tbody>
                                        <tr>
                                            <td><strong>Support</strong></td>
                                            <td>Supporting measures attention to "Airway, Breathing, Circulation, Disability, Exposure" (ABCDE), maintain hydration and nutrition.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Removal</strong></td>
                                            <td>Removal of the poison by emesis/gastric lavage. Use of activated charcoal.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Elimination</strong></td>
                                            <td>Accelerated elimination of the poison by diuresis, dialysis, hemoperfusion.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Specifics</strong></td>
                                            <td>Identification of the poison. Specific antidote, if available.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Coma Care</strong></td>
                                            <td>Patients with altered mental status should receive oxygen, IV glucose and IV thiamine (100 mg).</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 2.5: Antidotes for emergency treatment of certain poisonings</caption>
                                    <thead>
                                        <tr>
                                            <th>Poison</th>
                                            <th>Antidote</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Paracetamol</strong></td>
                                            <td>N-acetylcysteine</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Theophylline</strong></td>
                                            <td>Propranolol</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Mercury, arsenic and copper</strong></td>
                                            <td>BAL</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Atropine and other antimuscarinics</strong></td>
                                            <td>Physostigmine</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Carbon monoxide</strong></td>
                                            <td>Oxygen</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Cyanide</strong></td>
                                            <td>Dicobalt edetate; amyl nitrite followed by sodium nitrite, then sodium thiosulfate</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Methyl alcohol and ethylene glycol</strong></td>
                                            <td>Ethyl alcohol; 4-Methyl pyrazole</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Lead</strong></td>
                                            <td>Calcium disodium edetate; dimercaptosuccinic acid</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Nitrites</strong></td>
                                            <td>Methylene blue</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Opioids</strong></td>
                                            <td>Naloxone</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Benzodiazepines</strong></td>
                                            <td>Flumazenil</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Organophosphate compounds</strong></td>
                                            <td>Atropine; pralidoxime</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Warfarin</strong></td>
                                            <td>Vitamin K</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </section>
                    <!-- END: Chapter 2 -->

                    <!-- START: Chapter 3 -->
                    <section class="content-section" id="chapter-3">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìã</span>
                                Principles of Drug Prescribing and Drug Interactions
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Drug Prescribing</h3>
                            <p>A practitioner who prescribes drugs must know: Natural course of the disease he is treating, pharmacological actions and toxicity of a drug he uses, reasons for choosing a particular drug, methods of assessing drug efficacy and safety, and the possible interactions when several drugs are administered concurrently.</p>

                            <div class="callout callout--tip">
                                <div class="callout-header">
                                    <span class="callout-icon">üìù</span>
                                    <h4 class="callout-title">Table 3.1: Principles of prescription writing</h4>
                                </div>
                                <div class="callout-content">
                                    <p><strong>"Prescribe right drug to right patient in right dose by right route at right time intervals."</strong></p>
                                    <ul>
                                        <li>Write the prescription on your letterhead.</li>
                                        <li>Write legibly and indelibly.</li>
                                        <li>Write the patient's name, age and address. Do not abbreviate names of drugs/preparations(s) or instructions about taking the medicines. Write 'Units' not 'u'. Write mcg not ¬µg. When decimals are unavoidable, write, say, 50mcg, not 0.05mg.</li>
                                        <li>Write clearly dose (so many tablets/capsules/puffs), dosing interval (so many hours), time of the day, relation to meals, and duration of the therapy.</li>
                                        <li>When prescribing a drug 'as required', write the minimum dosing interval and the maximum number of doses per day.</li>
                                        <li>In case of scheduled drugs, write the quantity of drug to be supplied at a time and how many times the prescribed drugs may be supplied without revalidation.</li>
                                        <li>Sign the prescription.</li>
                                        <li>Write date and your registration number.</li>
                                        <li>Avoid painful IM injections in children whenever possible. Liquid preparations are more suitable for children and old persons.</li>
                                    </ul>
                                </div>
                            </div>

                            <p><strong>P-drug (Personal drug) Concept:</strong> P-drugs are the drugs one chooses for prescribing regularly and with which one becomes familiar. Such a list would spare the physician repeated search for a better drug from among the many available. Steps for selecting P-drugs:</p>
                            <ul>
                                <li>Define the diagnosis (Pathophysiology).</li>
                                <li>Specify the therapeutic objective(s).</li>
                                <li>Make an inventory of the effective drug groups.</li>
                                <li>Choose a group and select the individual drug from the group according to efficacy, safety, suitability and cost.</li>
                                <li>Prescribe treatment for a standard duration.</li>
                            </ul>

                            <p><strong>Essential Drugs:</strong> As per WHO definition: "Essential drugs are those drugs that satisfy the health care needs of the majority of the population. They should, therefore, be available at all times in adequate amounts and in appropriate dosage forms, at a price the individual and the community can afford."</p>

                            <p><strong>Orphan Drugs:</strong> Orphan drugs are drugs meant for the diagnosis, prevention or treatment of rare diseases. They are not easily available because their manufacture is not commercially-viable.</p>

                            <h3>Factors Modifying the Effects of a Drug</h3>
                            <p>Individuals differ both in the degree and the character of the response that a drug may elicit. The important factors which influence the effect of a drug are:</p>
                            <ul>
                                <li><strong>I Body weight:</strong> The average dose is mentioned either in terms of mg. per kg. body weight or as the total single dose for an adult weighing 50-100 kg.</li>
                                <li><strong>II Age and sex:</strong> Children may not react to all drugs in the same manner as young adults. The pharmacokinetics changes with age.
                                    <div class="table-responsive">
                                        <table class="comparison-table">
                                            <caption>Table 3.3: Determination of children's doses from adult doses on the basis of body surface area</caption>
                                            <thead>
                                                <tr>
                                                    <th>Weight (kg)</th>
                                                    <th>Approx. surface area in square meters</th>
                                                    <th>Approx. percentage of adult dose</th>
                                                </tr>
                                            </thead>
                                            <tbody>
                                                <tr><td><strong>2</strong></td><td>0.15</td><td>9</td></tr>
                                                <tr><td><strong>4</strong></td><td>0.25</td><td>14</td></tr>
                                                <tr><td><strong>6</strong></td><td>0.33</td><td>19</td></tr>
                                                <tr><td><strong>10</strong></td><td>0.46</td><td>27</td></tr>
                                                <tr><td><strong>20</strong></td><td>0.80</td><td>46</td></tr>
                                                <tr><td><strong>30</strong></td><td>1.08</td><td>62</td></tr>
                                                <tr><td><strong>50</strong></td><td>1.51</td><td>87</td></tr>
                                            </tbody>
                                        </table>
                                    </div>
                                    <p>Old people also present problems in dosage adjustment. In the elderly the body fat may increase while total water and lean body mass decrease. Liver and kidney mass and blood flow decreases.</p>
                                </li>
                                <li><strong>III Pregnancy and lactation:</strong> Special care should be exercised when drugs are prescribed during pregnancy and lactation (Chapter 80).</li>
                                <li><strong>IV Diet, Tobacco, Alcohol and Environment:</strong> Food can have significant effect on the pharmacokinetics of drugs. Tobacco smoke and alcohol induce hepatic microsomal CYP450 enzymes.</li>
                                <li><strong>V Route of administration:</strong> Intravenous doses of the drugs are usually smaller than oral doses.</li>
                                <li><strong>VI Psychological factors:</strong> The personality of the physician and patient may influence the drug effect (Placebo effect).</li>
                                <li><strong>VII Genetic factors:</strong> Variations in the human genome determine the genetically mediated differences in drug metabolism and response (pharmacogenomics). e.g., Acetylation status, G6PD deficiency.</li>
                                <li><strong>VIII Metabolic disturbances:</strong> Changes in water-electrolyte and acid-base balance modify effects.</li>
                                <li><strong>IX Presence of disease (Comorbidity):</strong> Hepatic or renal disease alters pharmacokinetics.</li>
                                <li><strong>X Cumulation:</strong> If a drug is excreted slowly, repeated administration may build up high concentration.</li>
                                <li><strong>XI Other drugs and chemicals:</strong> Drug interactions.</li>
                                <li><strong>XII Additive effect (Summation)</strong></li>
                                <li><strong>XIII Synergism</strong></li>
                                <li><strong>XIV Antagonism</strong></li>
                                <li><strong>XV Drug tolerance:</strong> When a large dose of a drug is required to elicit an effect ordinarily produced by its normal therapeutic dose. Includes Tachyphylaxis (acute tolerance).</li>
                                <li><strong>XVI Drug dependence:</strong> A state, psychic and sometimes also physical, resulting from the interaction between a living organism and a drug.</li>
                            </ul>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251214-7312ed26.jpeg" 
                                         alt="Effect of repeated doses of tyramine on BP" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 3.1: Effect of repeated doses of tyramine on BP in anaesthetised dog (Tachyphylaxis).</figcaption>
                            </figure>

                            <h3>Drug Interactions</h3>
                            <p>Drug interactions may result from the use of two or more drugs. This may lead to enhanced or diminished effect that may be useful or harmful.</p>
                            <ul>
                                <li><strong>Risky drugs:</strong> Those with steep dose-response curve, saturable kinetics, dose dependent toxicity, or low therapeutic index (e.g., warfarin, digoxin, lithium).</li>
                                <li><strong>Vulnerable patients:</strong> Elderly, patients with liver/kidney damage, unstable disease, or on multiple prescribers.</li>
                            </ul>
                            
                            <p><strong>I Drug interactions outside the body:</strong> Incompatibility in IV infusions (e.g. precipitation).</p>
                            <p><strong>II Drug interactions in the body:</strong></p>
                            <ul>
                                <li><strong>Pharmacokinetic:</strong> Affecting absorption (complex formation in gut), distribution (protein binding displacement), metabolism (enzyme induction or inhibition), or excretion (pH changes, competition for secretion).</li>
                                <li><strong>Pharmacodynamic:</strong> One drug altering the pharmacological action of another drug (at receptor site, or physiological antagonism).</li>
                            </ul>

                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 3.10 & 3.11: Drug Metabolism Interactions</caption>
                                    <thead>
                                        <tr>
                                            <th>Type</th>
                                            <th>Precipitant Drug</th>
                                            <th>Victim Drugs (Metabolism Affected)</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Enzyme Inducers</strong></td>
                                            <td>Barbiturates, Phenytoin, Rifampicin, Carbamazepine, Tobacco smoke</td>
                                            <td>Warfarin, Oral contraceptives, Glucocorticoids, Theophylline (metabolism accelerated, effect reduced)</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Enzyme Inhibitors</strong></td>
                                            <td>Cimetidine, Erythromycin, Ketoconazole, Ciprofloxacin, Fluoxetine</td>
                                            <td>Warfarin, Theophylline, Cyclosporine, Phenytoin (metabolism inhibited, toxicity increased)</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </section>
                    <!-- END: Chapter 3 -->

                    <!-- START: Chapter 4 -->
                    <section class="content-section" id="chapter-4">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß™</span>
                                Drug Invention; New Drug Development; and Drug Assay
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>A new drug is defined as a new substance of chemical, biological or biotechnological origin for which adequate data is not available for the regulatory authority to judge its efficacy and safety for the proposed claim. Modern drug development involves Computer-Aided Drug Design (CADD) and High Content Screening (HCS) to identify "hits and leads".</p>

                            <h3>Animal Toxicity Studies</h3>
                            <p>Important tests include:</p>
                            <ul>
                                <li><strong>Systemic toxicity studies:</strong> Single dose (to determine LD<sub>50</sub>) and Repeated dose studies.</li>
                                <li><strong>Local toxicity studies:</strong> Skin, eye irritation.</li>
                                <li><strong>Specialised toxicity studies:</strong> Male fertility, Female reproduction and fetal developmental toxicity (teratogenicity), Allergenicity, Genotoxicity (mutagenicity), and Carcinogenicity.</li>
                            </ul>

                            <h3>Clinical Evaluation</h3>
                            <p>Clinical Pharmacology involves the study of various aspects of pharmacodynamics and pharmacokinetics in humans.</p>
                            
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 4.2: Characteristics of various phases of the clinical trial</caption>
                                    <thead>
                                        <tr>
                                            <th>Characteristic</th>
                                            <th>PHASE 1</th>
                                            <th>PHASE 2</th>
                                            <th>PHASE 3</th>
                                            <th>PHASE 4</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Type</strong></td>
                                            <td>First in human (Human pharmacology)</td>
                                            <td>First in patient (Therapeutic exploratory)</td>
                                            <td>Multi-centre trial (Therapeutic confirmatory)</td>
                                            <td>Post-marketing surveillance</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Participants</strong></td>
                                            <td>10-100 Healthy volunteers</td>
                                            <td>50-500 Patients</td>
                                            <td>Hundreds to thousands of Patients</td>
                                            <td>Thousands (General population)</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Objective</strong></td>
                                            <td>Safety, tolerability, PK</td>
                                            <td>Efficacy, dose ranging</td>
                                            <td>Confirm efficacy, safety in larger population</td>
                                            <td>Rare ADRs, drug interactions, compliance</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Design</strong></td>
                                            <td>Open label</td>
                                            <td>Randomised controlled</td>
                                            <td>Randomised controlled (RCT)</td>
                                            <td>Open label</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <p><strong>Phase 0 studies:</strong> Exploratory, first-in-human studies with microdoses to obtain early PK data.</p>
                            
                            <p><strong>Placebo:</strong> An inert substance used to eliminate bias in clinical trials. Placebo effect is the effect attributable to a medicament as a procedure, not its specific pharmacodynamic property.</p>

                            <h3>Drug Assay</h3>
                            <ul>
                                <li><strong>Chemical assay:</strong> Estimation of mass concentration by chemical methods (e.g. spectrophotometry, HPLC).</li>
                                <li><strong>Bioassay:</strong> Estimation of concentration of active ingredient by measuring its effect on a suitable biological system (animal tissue/organ). Used when chemical composition is unknown or chemical method is insensitive (e.g. for hormones like Insulin, Oxytocin).
                                    <ul>
                                        <li><strong>International Unit (IU):</strong> A defined quantity of the standard preparation.</li>
                                    </ul>
                                </li>
                                <li><strong>Immunoassay:</strong> Depends on reaction between an antigen and specific antibody.
                                    <ul>
                                        <li><strong>Radio-immunoassay (RIA):</strong> Uses radiolabelled hormone.</li>
                                        <li><strong>ELISA:</strong> Enzyme Linked Immunosorbent Assay.</li>
                                    </ul>
                                </li>
                            </ul>
                            
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251214-be1b711c.jpeg" 
                                         alt="Radio-immunoassay principles" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig 4.1: Radio-immunoassay principles.</figcaption>
                            </figure>
                        </div>
                    </section>
                    <!-- END: Chapter 4 -->

                    <aside class="key-points-section" role="region" aria-labelledby="key-points-title">
                        <div class="key-points-wrapper">
                            <div class="key-points-header">
                                <span class="key-points-icon">‚≠ê</span>
                                <h3 id="key-points-title" class="key-points-title">Section I Key Points</h3>
                            </div>
                            <ul class="key-points-list">
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Pharmacokinetics</strong> is what the body does to the drug (Absorption, Distribution, Metabolism, Excretion).</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Pharmacodynamics</strong> is what the drug does to the body (Mechanism of action, Receptor interaction).</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Bioavailability</strong> is the fraction of administered drug that reaches the systemic circulation.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>First pass metabolism</strong> in the liver reduces bioavailability of oral drugs.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Half-life ($t^{1/2}$)</strong> determines the dosing interval and time to reach steady state.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Agonists</strong> activate receptors; <strong>Antagonists</strong> block receptors.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Therapeutic Index</strong> indicates the safety margin of a drug.</p>
                                </li>
                            </ul>
                        </div>
                    </aside>
                </main>
            </article>
            <nav class="document-nav">
                    <div class="nav-container">
                        <!-- Link back to Index since this is the first section -->
                        <a href="../index.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Back to</div>
                            <div class="nav-title">Table of Contents</div>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>1</span>
                                <span class="progress-separator">/</span>
                                <span>16</span>
                            </div>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 6.25%;"></div>
                            </div>
                            <div class="progress-label">Section 1 of 16</div>
                        </div>
                        
                        <a href="section-02.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Section II: CNS Drugs</div>
                        </a>
                    </div>
                </nav>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>